Location History:
- Munich, DE (1992 - 1994)
- Tutzing, DE (1990 - 2001)
Company Filing History:
Years Active: 1990-2001
Title: Lieselotte Schellong: Pioneering Innovations in Medical Analysis
Introduction
Lieselotte Schellong, based in Tutzing, Germany, is a renowned inventor recognized for her significant contributions to medical analysis through innovative methodologies. With a total of five patents to her name, Schellong's work primarily focuses on the accurate measurement of analytes in medical samples, addressing critical challenges in clinical diagnostics.
Latest Patents
Among her latest patents, the method for the analysis of medical samples containing haemoglobin stands out. This invention outlines a sophisticated technique for determining analyte concentrations in samples containing free haemoglobin. By employing optical measurement and implementing mathematical corrections, this method enables precise determination of critical parameters such as total protein, iron, and albumin in serum or plasma samples. The correction process involves measuring blank values and uncorrected analyte concentrations, ultimately leading to accurate readings.
Another significant invention is the reagent for the specific determination of fructosamine. This patent introduces a process that enhances the specificity of serum fructosamine content measurement in blood samples. By removing non-specific components and adjusting pH before the addition of a color reagent, this innovative method significantly improves the reliability of fructosamine detection.
Career Highlights
Lieselotte Schellong's career spans prestigious positions at notable companies in the medical diagnostics field, including Boehringer Mannheim and Roche Diagnostics. Her experiences in these leading organizations have enriched her expertise and fueled her passion for developing groundbreaking analytical methods.
Collaborations
Throughout her career, Schellong has collaborated with distinguished professionals such as Joachim Siedel and Bernd Vogt. Working alongside these experts, she has contributed to collective advancements in medical analysis, showcasing the importance of teamwork in fostering innovation.
Conclusion
Lieselotte Schellong exemplifies the spirit of innovation in medical analysis, with her latest patents reflecting a commitment to improving diagnostic accuracy. Her contributions not only advance the field but also enhance patient care by enabling healthcare professionals to make informed decisions based on reliable data. As she continues her journey, Schellong remains a vital figure in the landscape of medical invention and innovation.